BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Meridian Co. Ltd. (MRDAF) Becomes BC Reporting Issuer


2/5/2009 10:14:48 AM

VANCOUVER, BRITISH COLUMBIA--(Marketwire - February 05, 2009) - Meridian Co., Ltd., (OTCBB: MRDAF) a company engaged in the research, development, manufacturing, and sales of advanced medical devices, is pleased to announce that it has been deemed a reporting issuer in British Columbia.

Meridian is now filing regulatory period reports on Canada's System for Electronic Document Analysis and Retrieval (SEDAR) so that investors and shareholders all across Canada can download and view current regulatory reports filed by the Company. Canadian investors and shareholders now will enjoy the same access to Meridian's filings as our shareholders in the United States. Sedar filings can be viewed at http://www.sedar.com/homepage_en.htm.

Meridian is a leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 5 patents on its technology, and has received FDA approval, Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe. Meridian continues to successfully market its superior product line to a growing number of clients worldwide.

Safe Harbor Statement

This press release contains certain forward-looking information and statements concerning the company's future operations, performance and financial condition. These statements include that Meridian continues to successfully market its superior product line to a growing number of clients worldwide. Forward looking statements are subject to a number of risks, uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. Risk factors which could prevent the foregoing statements from being accurate include possible lesser market acceptance of our medical devices than anticipated. The Company does not update its forward looking information. This document is not intended to be and is not an advertisement for any securities of the Company.


Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-877-738-8119
Website: www.meridianmedical.ca



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES